PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-23.20%
Negative net income growth while CRK stands at 6.49%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
3.21%
Some D&A expansion while CRK is negative at -16.31%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-66.67%
Negative yoy deferred tax while CRK stands at 38.16%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-230.43%
Negative yoy SBC while CRK is 22.53%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
19.38%
Less working capital growth vs. CRK's 307.44%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-52.86%
Both yoy AR lines negative, with CRK at -271.53%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.57%
Lower 'other working capital' growth vs. CRK's 9285.91%. David Dodd would see fewer unexpected short-term demands on cash.
-2600.00%
Negative yoy while CRK is 177.46%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
105.66%
Operating cash flow growth below 50% of CRK's 1531.06%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-4.01%
Both yoy lines negative, with CRK at -23.51%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
286.05%
Acquisition growth of 286.05% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
4.01%
Purchases growth of 4.01% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-56.36%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-4.01%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
19.64%
We have mild expansions while CRK is negative at -23.51%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-50.00%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.